FROM
Huffpost Healthy Living
Click link below picture
.
One of the fastest-moving fields in cancer research, epigenetics is the study of changes that influence how DNA does its job. Some of these alterations have been shown to cause cancer. Unlike most existing cancer drugs, which work by destroying cancer cells, therapies that target epigenetic changes have the potential to reprogram the diseased cells and set them on a path back toward normal growth and development.
Physician-scientists like myself and others at Memorial Sloan Kettering (MSK) are exploring a number of new drugs that interfere with certain epigenetic processes. If such drugs prove to be safe and effective in clinical trials, they may eventually offer a groundbreaking approach to cancer treatment.
As we look forward to the new possibilities that a new year brings, here are just a few reasons my colleagues and I are hopeful about the promise this…
View original post 20 more words
James' World 2 
Leave a comment